There are a number of GLP-1 medications on the market, but they all work by slowing down gastric emptying, making you feel full faster and longer
Innovations, such as oral formulations and dual-target agonists, are reshaping competitive positioning
Keep pinching up skin, and check with your doctor if youre unsure
Integrated Research Applications GLP-1S is used in research to examine incretin biology, receptor signaling, and metabolic control
Semaglutide (Ozempic/Wegovy) got FDA approval, then demand outstripped supply, so it went on the "drug shortage list." That shortage list temporarily opened a legal door for compounding pharmacies to make their own versions
This triple-receptor mechanism distinguishes it from existing authorised agents such as semaglutide (GLP-1 agonist, available as Wegovy and Ozempic) or tirzepatide (GLP-1/GIP dual agonist, available as Mounjaro)